Efficacy of liraglutide in non-insulin-dependent diabetic patients with GAD autoantibody -positive
Not Applicable
Completed
- Conditions
- Diabetes
- Registration Number
- JPRN-UMIN000010043
- Lead Sponsor
- niversity of Yamanashi, Faculty of Medicine Department of Internal Medicine III
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1. Ketosis 2. Pregnant, or intention of becoming pregnant 3. Patients who has serious complication or concurrent disease 4. Any other condition which the investigator feels would interfere with the participation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in s-CPR after oral glucose tolerance test
- Secondary Outcome Measures
Name Time Method 1. Percentage of withdrawn patients whose HbA1c are over 9.4%(NGSP) at two consecutive times measurements and the term until withdrawal. 2. Change in blood glucose level after oral glucose tolerance test every 6-month. 3. Change in HbA1c 4. Change in fasting plasma glucose 5. Change in fasting s-CPR 6. Change in circadian variability of blood-glucose 7. Change in weight 8. Change in blood pressure. 9. Change in islet autoantibodies (GAD antibody, IA-2 antibody, Insulin antibody, ZnT8 antibody)